Celldex Therapeutics
CLDX
#4616
Rank
A$2.91 B
Marketcap
A$43.77
Share price
1.37%
Change (1 day)
40.50%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2025 (TTM): -A$0.4 Billion

According to Celldex Therapeutics's latest financial reports the company's current earnings are A$2.6 Million. In 2024 the company made an earning of -A$0.28 Billion a decrease over its 2023 earnings that were of -A$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.4 Billion45.58%
2024 -A$0.28 Billion37.34%
2023 -A$0.2 Billion32.63%
2022 -A$0.16 Billion54.88%
2021 -A$97.16 Million39.49%
2020 -A$69.66 Million-9.08%
2019 -A$76.61 Million-28.64%
2018 -A$0.11 Billion-30.11%
2017 -A$0.16 Billion-17.75%
2016 -A$0.19 Billion4.5%
2015 -A$0.18 Billion4.09%
2014 -A$0.18 Billion51.57%
2013 -A$0.12 Billion40.1%
2012 -A$80.86 Million
2010 -A$1.76 Million-96.59%
2009 -A$51.43 Million
2006 -A$31.43 Million
2004 -A$19.09 Million15.75%
2003 -A$16.49 Million-18.69%
2002 -A$20.28 Million-41.22%
2001 -A$34.5 Million59%
2000 -A$21.7 Million27.65%
1999 -A$17 Million53.12%
1998 -A$11.1 Million2.6%
1997 -A$10.82 Million-33.62%
1996 -A$16.3 Million-1.69%
1995 -A$16.58 Million22.92%
1994 -A$13.49 Million-0%
1993 -A$13.49 Million
1991 -A$8.29 Million90.32%
1990 -A$4.36 Million10.71%
1989 -A$3.94 Million833.33%
1988 -A$0.43 Million-400%
1987 A$0.14 M-125%
1986 -A$0.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$16.65 B-4,725.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.58 B-3,317.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.09 B-3,738.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-A$3.95 Million-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-A$1.12 Billion 208.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$29.03 M-108.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-164.51%๐Ÿ‡บ๐Ÿ‡ธ USA